Galapagos NV
GLPG
#5081
Rank
ยฃ1.39 B
Marketcap
ยฃ20.77
Share price
0.00%
Change (1 day)
-1.67%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ0.10 Billion

According to Galapagos NV's latest financial reports the company's total liabilities are ยฃ0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2026)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ1.02 B-24.2%
2023-12-31ยฃ1.35 B-30.79%
2022-12-31ยฃ1.95 B-8.47%
2021-12-31ยฃ2.13 B-22.2%
2020-12-31ยฃ2.74 B0.81%
2019-12-31ยฃ2.72 B1243.68%
2018-12-31ยฃ0.20 B-16.64%
2017-12-31ยฃ0.24 B-12.01%
2016-12-31ยฃ0.27 B383.87%
2015-12-31ยฃ57.19 M13.81%
2014-12-31ยฃ50.25 M-50.08%
2013-12-31ยฃ0.10 B5.24%
2012-12-31ยฃ95.65 M168.25%
2011-12-31ยฃ35.65 M-8.95%
2010-12-31ยฃ39.16 M27%
2009-12-31ยฃ30.83 M-6.29%
2008-12-31ยฃ32.9 M-10.63%
2007-12-31ยฃ36.82 M-5.93%
2006-12-31ยฃ39.14 M178.94%
2005-12-31ยฃ14.03 M278.56%
2004-12-31ยฃ3.7 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
ยฃ89.66 B 86,768.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ43.24 B 41,791.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ107.17 B 103,725.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ47.58 B 45,995.08%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ61.98 B 59,952.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ49.91 B 48,252.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ45.08 B 43,575.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
ยฃ87.05 M-15.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ23.82 B 22,982.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel